U.S. Scalp Cooling Systems Market Size, Share, and Growth Forecast for 2025 - 2032

The United States scalp cooling systems market was valued at US$ 27.1 million in 2025 and is expected to reach US$ 46.1million by the end of 2032, expanding rapidly at a CAGR of 7.9%.

Cancer treatment centers usually have more possibilities for the use of scalp cooling systems. The Food and Drug Administration (FDA) has reviewed and approved several scalp cooling devices, including DigniCap, for use in breast cancer treatments. Increasing awareness of scalp cooling systems among the general population is creating an opportunity for new market players.

• Revenue from the sales of scalp cooling systems in the United States accounted for 0.2% share of the global chemotherapy devices market in 2024.
• Manual cooling systems/cold gel caps are leading the product segment and accounted for a market share of 72.6% in 2024.
• Rental sales accounted for 84.9% share of the U.S. scalp cooling systems market in 2024.

Manual cooling systems, also known as cold gel caps, are a type of scalp cooling system that is used to reduce hair loss in cancer patients undergoing chemotherapy. These systems consist of a special gel-filled cap that is frozen prior to use and then worn during chemotherapy treatment. The cap is typically worn for several hours before, during, and after each chemotherapy session. The cold temperature of the cap constricts the blood vessels of the scalp, reducing the intensity of chemotherapy drugs that reach the hair follicles and cause hair loss.

Sales of scalp cooling systems in the United States increased at a CAGR of 7.7% from 2019 to 2024, driven by a rise in the elderly population in the country.

There is increased awareness among cancer patients and healthcare providers about the benefits of scalp cooling in reducing chemotherapy-induced hair loss. Advancements in scalp cooling systems are also anticipated to propel their demand in the United States. The market for scalp cooling systems is also expected to grow at a fast pace as cancer patients are becoming more aware of these systems and healthcare providers continue to offer them as an option. The aging population and the increasing incidence of cancer are expected to complement the demand growth for scalp cooling devices in the United States

• According to a study published by the American Cancer Society in 2022, there were 609,360 cancer deaths and an estimated 1.9 million newly diagnosed cancer cases in the United States in 2022.
• In October 2022, the World Health Organization predicted that between 2015 and 2050, the percentage of people above 60 years of age in the world would rise from 12% to 22%, demonstrating a rapidly rising aging population.

Since chronic diseases such as cancer have become more common, many therapeutic modalities have been developed to treat these ailments. The market for scalp cooling systems in the country is expected to witness significant growth over the coming years due to increasing demand from cancer patients, rising investments in cancer care, and technological advancements in products.

All in all, demand for scalp cooling systems in the United States is expected to increase at a CAGR of 7.9% from 2025 to 2032.

“Technological Advancements and Increasing Funding to Support Cancer Care”

Scalp cooling systems are widely used in cancer treatment to reduce hair loss caused by chemotherapy. As the demand for these systems increases, manufacturers of scalp cooling systems are exploring several opportunities such as expanding their market share, technological advancements, partnerships with other companies, research and development, etc.

Cancer patients seek efficient scalp-cooling solutions, which is expected to result in the growth of the target market. Manufacturers can capitalize on this trend by expanding their product offerings and increasing their market share. Additionally, the government is increasing funding in this area to support patients in their quest to stop hair loss. To prevent hair loss while receiving cancer treatment, scalp cooling is proving to be an increasingly useful method.

Simple scalp cooling treatments can stop hair loss caused by some chemotherapy medications but the cost of the treatment is high, which is not affordable for many patients. This is why the government has been stepping in to support patients for scalp cooling treatments, which is an opportunity for manufacturers.

“Lack of Experience in Equipment Handling and High Cost of Installation & Setup”

Trained and skilled staff are needed to handle automated scalp cooling systems. Many hospitals lack the required professionals who can handle advanced and precise automated scalp cooling systems.

Across the country, the demand for qualified specialists and professionals is increasing at a rapid pace due to the increasing prevalence of oncology diseases and the growing geriatric population. However, the limited number of skilled professionals and operators is expected to hinder the growth of the market to some extent.

Installation and setup costs of scalp cooling systems are also very high. Both manual and automatic scalp cooling systems require advanced technology, which drives up the cost of the equipment as well as the cost of setting it up. Scalp cooling systems are a new advanced technology. Moreover, thorough training is required to use these advanced systems.

Which Product Accounts for High Sales in This Market?

“High Demand for Manual Cooling Systems/Cold Gel Caps”

Demand for manual cooling systems/cold gel caps is expected to rise at a CAGR of 6.9% through 2032. Manual cooling systems/cold gel caps accounted for a market share of 72.6% in 2024.

Manual cooling systems/cold gel caps are less expensive than some of the automated scalp cooling systems available in the market. They are also portable and can be used in the comfort of a patient's home. Manual cooling systems/cold gel caps remain a popular option for many cancer patients due to their effectiveness, affordability, and ease of use.

Which Sales Type Accounts for High Revenue Generation for Scalp Cooling System Manufacturers?

“Rental Sales Most Cost-Effective Option for Cancer Patients”

Rental sales accounted for 84.9% share of the market and are anticipated to increase at a CAGR of 7.6% from 2025 to 2032. This segment accounts for a higher market share since it is the most cost-effective option available.

Renting a scalp cooling system is a more cost-effective option for cancer patients who may not want to purchase a device outright or may not have the financial means to do so. Rental programs allow patients to use the device for the duration of their treatment without having to worry about the upfront cost of purchasing the device. While this is a clear benefit for them, it also allows the system owner to keep renting it out, thereby aiding revenue generation.

Where is There High Deployment of Scalp Cooling Systems?

“Specialized Cancer Care Units in Hospitals Account for High Revenue Share”

In 2024, hospitals accounted for 44.8% market share. Hospitals are mostly the first point of contact for cancer patients and offer a readily available and accessible platform for scalp cooling systems. Many hospitals have specialized cancer care units that offer scalp cooling services, which increases the availability of these systems for patients in these settings.

Many hospitals have research and development programs that focus on improving cancer care, including the use of scalp cooling systems. This leads to advancements in technology and improved efficacy of scalp cooling machines in reducing hair loss during chemotherapy.

The U.S. is a high-niche market for scalp cooling systems due to the presence of fewer competitors. To maintain their position in the market, these leading players are implementing various strategies. They are expanding their operations into emerging regions of the country, developing new and improved products, and improving their sales channels through online advertising, all aimed at strengthening their market presence across the United States.

Additionally, key market players are adopting the strategy of launching new and advanced products to solidify their position in the market.

• On September 27, 2018, the updated model of the PAXMAN scalp cooling system was introduced by PAXMAN.

Key players in the market are constantly involved in the development of improved technologies that are expected to meet the needs of patients. Technological advancements are also increasing with rising competition among market players. The focus is mainly to develop painless technology that does not involve surgical procedures.

• On January 26, 2023, the Paxman scalp cooling system received European Medical Device Regulation standards approval.

By Product:

• Manual Cooling Systems/Cold Gel Caps
• Automated Cooling Systems

By Sales Type:

• Direct Sales
• Rental Sales

By End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Homecare Settings

By Region:

• Northeast
• Midwest
• Southeast
• Southwest
• West